[HTML][HTML] Vaccine value profile for Neisseria gonorrhoeae

Y Lyu, A Choong, EPF Chow, KL Seib, HS Marshall… - Vaccine, 2023 - Elsevier
Neisseria gonorrhoeae infection (gonorrhoea) is a global public health challenge, causing
substantial sexual and reproductive health consequences, such as infertility, pregnancy …

Neisseria gonorrhoeae vaccines: a contemporary overview

E Williams, KL Seib, CK Fairley… - Clinical Microbiology …, 2024 - Am Soc Microbiol
Neisseria gonorrhoeae infection is an important public health issue, with an annual global
incidence of 87 million. N. gonorrhoeae infection causes significant morbidity and can have …

[HTML][HTML] Exploitation of Neisseria meningitidis group B OMV vaccines against N. gonorrhoeae to inform the development and deployment of effective gonorrhea …

H Petousis-Harris, FJ Radcliff - Frontiers in immunology, 2019 - frontiersin.org
Have potential clues to an effective gonorrhea vaccine been lurking in international disease
surveillance data for decades? While no clinically effective vaccines against gonorrhea have …

Advancing vaccine development for gonorrhoea and the Global STI Vaccine Roadmap

SL Gottlieb, AE Jerse, S Delany-Moretlwe, C Deal… - Sexual …, 2019 - CSIRO Publishing
Efforts to develop vaccines against Neisseria gonorrhoeae have become increasingly
important, given the rising threat of gonococcal antimicrobial resistance (AMR). Recent data …

Planning for a gonococcal vaccine: a narrative review of vaccine development and public health implications

WE Abara, AE Jerse, S Hariri… - Sexually transmitted …, 2021 - journals.lww.com
Declining gonococcal susceptibility to ceftriaxone and azithromycin has raised the possibility
of untreatable gonorrhea in the future and reignited interest in gonococcal vaccine …

Evaluating vaccine-elicited antibody activities against Neisseria gonorrhoeae: cross-protective responses elicited by the 4CMenB meningococcal vaccine

MC Gray, KS Thomas, ER Lamb, LM Werner… - Infection and …, 2023 - Am Soc Microbiol
The bacterial pathogen Neisseria gonorrhoeae is an urgent global health problem due to
increasing numbers of infections, coupled with rampant antibiotic resistance. Vaccines …

Urgent Need to Understand and Prevent Gonococcal Infection: From the Laboratory to Real-World Context

Y Ruiz García, J Marrazzo… - The Journal of …, 2024 - academic.oup.com
Neisseria gonorrhoeae is widespread globally. Primary prevention is unsuccessful and
antimicrobial resistance threatens optimal management. There is no specific vaccine and …

Proof of principle for effectiveness of a gonorrhoea vaccine

M Unemo, AE Sikora - Nature Reviews Urology, 2017 - nature.com
Antimicrobial resistance in Neisseria gonorrhoeae compromises gonorrhoea treatment
globally and vaccines might be the only sustainable solution for gonorrhoea control. A new …

Insight into Prevention of Neisseria Gonorrhoeae: A Short Review

V La Fauci, D Lo Giudice, R Squeri, C Genovese - Vaccines, 2022 - mdpi.com
Neisseria gonorrhoeae (gonococcus) and Neisseria meningitidis (meningococcus) are
important global pathogens which cause the sexually transmitted diseases gonorrhea and …

An open-label randomised controlled trial evaluating the efficacy of a meningococcal serogroup B (4CMenB) vaccine on Neisseria gonorrhoeae infection in gay and …

C Thng, EA Semchenko, I Hughes, M O'Sullivan… - BMC Public Health, 2023 - Springer
Background Gonorrhoea is an ongoing public health concern due to its rising incidence and
the emergence of antibiotic resistance. There are an estimated 82 million new Neisseria …